Proposed Bipartisan Cancer Drug Parity Act Extends Treatment Protections for Privately Insured Cancer Patients
Legislation introduced by U.S. Congressmen Leonard Lance (R–N.J.) and Brian Higgins (D–N.Y.) would ensure that the estimated 60 percent of Americans whose private health benefits are regulated by federal law will receive cost-sharing parity for orally administered cancer treatments. Although 43 states have already passed oral parity laws, there are still privately insured patients who do not have the assurance that they will receive equal access to orally administered cancer drugs as to cancer therapies administered by other methods. Read more here.